NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $818,000 | -6.2% | 9,681 | -2.6% | 0.41% | +9.7% |
| Q1 2022 | $872,000 | +0.3% | 9,936 | 0.0% | 0.37% | +5.1% |
| Q4 2021 | $869,000 | +6.9% | 9,936 | 0.0% | 0.35% | -2.2% |
| Q3 2021 | $813,000 | -10.4% | 9,936 | 0.0% | 0.36% | -9.3% |
| Q2 2021 | $907,000 | +6.8% | 9,936 | 0.0% | 0.40% | +0.5% |
| Q1 2021 | $849,000 | -9.5% | 9,936 | 0.0% | 0.40% | -15.5% |
| Q4 2020 | $938,000 | +8.6% | 9,936 | 0.0% | 0.47% | -1.7% |
| Q3 2020 | $864,000 | -1.7% | 9,936 | -1.2% | 0.48% | -7.7% |
| Q2 2020 | $879,000 | +5.9% | 10,061 | 0.0% | 0.52% | -9.3% |
| Q1 2020 | $830,000 | -16.2% | 10,061 | -3.7% | 0.57% | +47.2% |
| Q4 2019 | $990,000 | +8.7% | 10,451 | -0.3% | 0.39% | +5.1% |
| Q3 2019 | $911,000 | -4.8% | 10,486 | 0.0% | 0.37% | -6.6% |
| Q2 2019 | $957,000 | – | 10,486 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |